InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricated novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).
Products, services, technology
We support pharmaceutical and nutraceutical companies to design drug delivery systems with added value (e.g., novel biomaterial formulation and manufacturing).
InkVivo's technology can used to provide temporal controlled release of small molecules, biologics, and micronutrients.
Cooperation possibilities
InkVivo offers an agile and scalable approach to develop drug delivery systems. With our technology it is possible to repurpose and to reformulate existing active ingredients (both patented or in clinical trials). Moreover, we provide an effective strategy to extend lifecycle of existing products.
- https://inkvivo.tech
- +41 76 373 51 35
- elia.guzzi@inkvivo.tech
- Elia Guzzi
Some insights
InkVivo's biomaterial platform and manufacturing technology have the potential to improve a broad range of products used in our daily life with a special focus on health, nutrition, and sustainability. These products will improve the quality of life of several patients, our end costumers.
InkVivo's technology is based on >5 years of research and development at ETH Zurich. Our platform technology can be used to solve several challenges in the field of advanced drug delivery system, such as pharmaceutical, nutraceutical, and cosmetic products
The co-founder and advisory team provides complementary skills: a strong technical background with business and financial expertise.
To further strengthen our company, we are looking for serial entrepreneurs in the field of life science and food industry.
We would like to expand our network in term of investors and industrial partners. This would allow us to further develop our business and accelerate our market entry.
We would like to expand our network in term of investors and industrial partners. This would allow us to further develop our business and accelerate our market entry.